Actively Recruiting
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Led by University of Alberta · Updated on 2026-04-13
150
Participants Needed
4
Research Sites
533 weeks
Total Duration
On this page
Sponsors
U
University of Alberta
Lead Sponsor
M
McGill University
Collaborating Sponsor
AI-Summary
What this Trial Is About
CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.
CONDITIONS
Official Title
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must have ALS or a related disorder classified by specific criteria or be asymptomatic with a known ALS mutation
- Participants must be of legal adult age in their province
- Participants must be able to provide informed consent
- Participants must be proficient in English or French to follow study instructions and complete questionnaires
- Healthy controls must be aged 40 to 80 or age-matched within 3 years to a patient participant
- Healthy controls must be of legal adult age in their province
- Healthy controls must be able to provide informed consent
- Healthy controls must be proficient in English or French to follow study instructions and complete questionnaires
You will not qualify if you...
- Healthy controls cannot have a history of neurological diseases such as stroke, head injury, epilepsy, neuropathy, or myopathy
- Healthy controls cannot have a clinical diagnosis of psychiatric disease or be currently using psychiatric medications for such conditions
- Participants ineligible for MRI due to pacemakers or other contraindications according to local policies cannot participate
- Participants with significant claustrophobia preventing MRI scanning cannot participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
2
University of Toronto / Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
3
McGill University / Montreal Neurological Institute and Hospital
Montreal, Quebec, Canada, H4A2H6
Actively Recruiting
4
CHU de Quebec -Universite de Laval
Québec, Quebec, Canada, G1J 1Z
Actively Recruiting
Research Team
C
Claire Magnussen, PhD
CONTACT
S
Sara Moradipoor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here